Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Bio...( ...),Health

OLDSMAR, Fla., Aug. 6 /PRNewswire-FirstCall/ -- Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL), one of the largest and most established leaders in stem cell innovation, will present data on the proliferative ability of stem cells found in menstrual blood (known as MenSCs) during the Fourth China Medical Biotech Forum, August 8-10 in Dalian, China. Data from an in vitro study show that MenSCs proliferate rapidly and have significant potential to develop into multiple cell types. Dr. Julie Allickson, Vice President of Laboratory Operations and Research and Development at Cryo-Cell, will present the data at the Forum as part of a keynote address.

Study Overview

The data being presented are based on research conducted by Cryo-Cell International, who discovered the menstrual stem cells. The data show that MenSCs have the capability to differentiate rapidly and plentifully into stem cells, such as bone, cartilage, fat, nerve and cardiogenic cells. These findings demonstrate that menstrual stem cells are easily expandable to clinical relevance and may potentially have applications in a variety of conditions. Using Cryo-Cell's proprietary C'elle(SM) system, MenSCs are currently being studied for potential therapeutic applications for possible future treatment of disorders such as stroke; diabetes; vascular regeneration; breast cancer; wound management; endometriosis and female urinary incontinence.

"We are pleased to share these promising early study findings with the distinguished researchers attending the CMBF," said Dr. Allickson. "MenSCs are sufficiently potent and could potentially be used in the future for a variety of therapies and conditions, and we look forward to gaining further insights from the current clinical trials testing the safety and efficacy of the cells in several different animal models."

The C'elle service is based on Cr
'/>"/>